MedTrace Logo

Efficacy of Brief Acceptance and Commitment Therapy (ACT) for Perinatal Anxiety

NCT03837392 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2023-07-12

No results posted yet for this study

Summary

This protocol will test the hypothesis that Acceptance and Commitment Therapy (ACT) is effective in reducing anxiety and depressive symptoms during the perinatal and postpartum periods. Participants should expect their participation in the study to last 9-12 months.

Conditions

  • Post Partum Depression
  • Perinatal Depression
  • Post Partum Anxiety
  • Perinatal Anxiety

Interventions

DIAGNOSTIC_TEST

Baseline Assessment (18-26 weeks pregnant)

At baseline, participants will complete several interviews and questionnaires online and via phone to determine psychological history, current functioning, history of trauma, coping styles, and demographic variables.

BEHAVIORAL

Online Intervention and Phone Coaching Interventions

ACT is a cognitive-behavioral therapy that seeks to promote psychological flexibility. The active comparator is the Supportive Control. Two phone coaching sessions will occur 2- and 4-weeks post-intervention in both conditions.

DIAGNOSTIC_TEST

Follow Up Assessments: 34-36 weeks pregnant and 4-week postpartum

The follow-up assessments at 34-36 weeks pregnancy and 4-weeks postpartum will be completed via REDCap, an online secure survey platform in order to reduce participant burden.

DIAGNOSTIC_TEST

Follow Up Assessments: 8 weeks postpartum

The follow-up assessment at 8-weeks postpartum will be completed via phone.

Sponsors & Collaborators

  • University of Iowa

    lead OTHER

Principal Investigators

  • Emily B K Thomas, PhD · University of Iowa

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-06-01
Primary Completion
2023-01-31
Completion
2023-06-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03837392 on ClinicalTrials.gov